Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - Common Dividends Paid - Common Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt repayments

Daily Values

Growth Metrics

Calavo Growers (CVGW) Asset Writedowns and Impairment (2017 - 2024)

Calavo Growers has reported Asset Writedowns and Impairment over the past 9 years, most recently at $165000.0 for Q1 2024.

Quarterly results put Asset Writedowns and Impairment at $165000.0 for Q1 2024, down 88.25% from a year ago — trailing twelve months through Oct 2024 was $165000.0 (down 93.33% YoY), and the annual figure for FY2024 was $165000.0, down 93.33%.
Asset Writedowns and Impairment for Q1 2024 was $165000.0 at Calavo Growers, down from $1.1 million in the prior quarter.
Over the last five years, Asset Writedowns and Impairment for CVGW hit a ceiling of $1.4 million in Q1 2023 and a floor of $165000.0 in Q1 2024.